{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 48,
        "end": 56
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 118,
        "end": 131
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 199,
        "end": 206
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 59,
        "end": 68
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 39,
        "end": 76
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 79,
        "end": 82
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "21457551_10",
  "text": "In postmenopausal women who were using combined estrogen - progestin therapy ( EPT ) at cohort enrollment , the OR of breast cancer was 2.31 ( 95 % CI = 1.47-3 .62 ) per minor allele of rs4149013 in SLCO1B1 ( P = 0.0003 ; within-gene PACT = 0.002 ; overall PACT = 0.023 ) ."
}
